Matching-Adjusted Indirect Comparison of the Efficacy at Week 32 of Tralokinumab and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis

• Главные авторы: Tiago Torres (Автор), Anne Sohrt Petersen (Автор), Ulla Ivens (Автор), Albert Bosch Vilaro (Автор), John Stinson (Автор), José Manuel Carrascosa (Автор)
• Формат: ‌
• Опубликовано: Adis, Springer Healthcare, 2024-04-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Abstract Introduction Tralokinumab and dupilumab are biological agents licensed for the treatment of moderate-to-severe atopic dermatitis (AD) in adult patients who are candidates for systemic treatment. However, no head-to-head studies of their efficacy have been conducted. This study indirectly co...